Aktiesnakken — September 2013
-
73,5 i HLF, mon Bill Ackmann skider grønne grise?
-
det er nok også aktuelt hvordan patienterne gør. Hvad siger Roche hvis Arzerra er bedre på CR, duration of response, samt langt bedre på bivirkninger og 22,6 mod 23 i PFS måneder
-
herunder er de 22,6 vurderet strengere end de 23 (via investigator review)
-
Golf check mit SPPI chart her: http://www.proinvestor.com/index.php?p=debat_post&postid=66487 sådan ser jeg den pt. og syntes det ligner udbrud ud af den lange nedtrend
-
Novod: on par with roche http://medwatch.dk/Top_picks_in_english/article5963089.ece#.Ujg9GajqsUQ.twitter
-
altså nu kan jeg ikke forudsige en aktie skal stige 50%, men det er et bud rent teknisk

-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind